Recombinant Endoglin / CD105 (Angiogenesis Marker) Antibody, IgG1, Clone: [ENG/8069R], Mouse, Monoclonal

Artikelnummer: NBT-2022-RBM11-P1ABX
Artikelname: Recombinant Endoglin / CD105 (Angiogenesis Marker) Antibody, IgG1, Clone: [ENG/8069R], Mouse, Monoclonal
Artikelnummer: NBT-2022-RBM11-P1ABX
Hersteller Artikelnummer: 2022-RBM11-P1ABX
Alternativnummer: NBT-2022-RBM11-P1ABX-100
Hersteller: NeoBiotechnologies
Wirt: Mouse
Kategorie: Antikörper
Applikation: IHC
Spezies Reaktivität: Human
Immunogen: Recombinant fragment of human Endoglin protein (exact sequence is proprietary)
Alternative Synonym: CD105, END, Endoglin, Eng, HHT1, S-endoglin
CD105/Endoglin is a Type I membrane glycoprotein located on cell surfaces and is part of the TGF-beta receptor complex. This protein has been found on endothelial cells, activated macrophages, fibroblasts, and smooth-muscle cells. Endoglin has a role in the development of the cardiovascular system and in vascular remodeling. Its expression is regulated during heart development. CD105 is highly expressed in endothelial cells during tumor angiogenesis and inflammation, with weak or negative expression in vascular endothelium of normal tissues. Angiogenesis is a promising prognostic marker in a variety of tumors. Endoglin is a more specific and sensitive marker for tumor angiogenesis than CD31 or CD34, as it labels only newly-formed blood vessels and may serve as a prognostic marker for Prostate Adenocarcinoma, and cancers of the lung, stomach, breast, and brain.
Klonalität: Monoclonal
Klon-Bezeichnung: [ENG/8069R]
Molekulargewicht: 80kDa (Monomer), 160kDa (Homodimer)
Isotyp: IgG1
NCBI: 2022
UniProt: P17813
Formulierung: 200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.
Formalin-fixed, paraffin-embedded human placenta stained with Endoglin / CD105 Recombinant Rabbit Monoclonal Antibody (ENG/8069R) Inset: PBS instead of primary antibody, secondary only negative control.